New technique protects ‘architecture’ of insulin-producing islet cells for transplant into type 1 diabetics

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic for type 1 diabetes that overcomes the need to obtain islet cells from deceased donors.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup